Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
39.39
+0.04 (+0.10%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
32
33
Next >
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
July 21, 2023
Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.
Via
InvestorPlace
Why Shares of Vir Biotechnology Are Plunging Thursday
July 20, 2023
The company had disappointing trial news for one of its lead therapies.
Via
The Motley Fool
A Look Into GSK's Debt
July 17, 2023
Via
Benzinga
Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
July 13, 2023
HC Wainwright has upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Sell, with a price target of
Via
Benzinga
7 Stocks That AI Says Will Make You a Millionaire by 2025
July 13, 2023
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio.
Via
InvestorPlace
3 Healthcare Stocks With Healthy Dividends
July 13, 2023
These pharmaceutical companies all combine relatively high dividends with safe payout ratios.
Via
The Motley Fool
GSK's RSV Vaccine Scores Approval In UK For Older Adults
July 10, 2023
The U.K.
Via
Benzinga
(GSK) - Analyzing GSK's Short Interest
July 07, 2023
Via
Benzinga
Better Artificial Intelligence Stock: GSK or Eli Lilly?
June 28, 2023
Which of these AI-powered drugmakers is the better buy right now?
Via
The Motley Fool
GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US
July 13, 2023
From
GSK plc
Via
Business Wire
3 No-Brainer Stocks to Buy With $50 Right Now
July 12, 2023
You don't need a treasure chest full of cash to begin building wealth on Wall Street.
Via
The Motley Fool
Why Are NanoViricides Shares Gaining Today
July 11, 2023
NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for
Via
Benzinga
Meta's Threads Hits 100M Users In Five Days, Foxconn Pulls Out From $19.5B Semiconductor India JV, Novo Nordisk's Weight-Loss Medications Under European Investigation Over Suicidal Risks: Today's Top Stories
July 10, 2023
Benzinga
Via
Benzinga
Is GSK a Strong Buy Right Now?
June 26, 2023
The drugmaker ought to appeal to value and income investors.
Via
The Motley Fool
2 Stocks Defying Friday's Market Downturn
June 23, 2023
Stock markets opened lower as Wall Street took a pause from the bull run.
Via
The Motley Fool
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...
Via
Benzinga
Analyst Creates Bullish Pitch For WAVE Life Sciences, Says It Is 'Leader To Clinic In RNA Editing'
July 05, 2023
Raymond James has initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a price target of $9 and
Via
Benzinga
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
July 05, 2023
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.
Via
Benzinga
Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults
July 05, 2023
Moderna Inc (NASDAQ: MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease in
Via
Benzinga
Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products
July 05, 2023
Haleon Plc (NYSE: HLN), a consumer health company, is reportedly considering divesting some smoking cessation products as part of a strategy to sell non-core businesses.
Via
Benzinga
First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California
July 03, 2023
The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the plaintiffs.
Via
Benzinga
Drugmaker GSK: Becoming a Healthier Value Stock
June 27, 2023
Up more than 25% in the last nine months, U.K. pharmaceutical company GSK PLC is slowly regaining favor with investors after the GSK lawsuit.
Via
MarketBeat
Topics
Lawsuit
Exposures
Financial
Legal
Baidu Says Ernie Bot Beats ChatGPT, Meta's WhatsApp Business Soars Past 200M Users, Walgreens Earnings Disappointment: Today's Top Stories
June 27, 2023
CNBC ChatGPT Vs. Baidu's Ernie Bot - Chinese Tech Giant Says Ernie Beat ChatGPT
Via
Benzinga
Second Most Prevalent Bacterial Sexually Transmitted Infection: GSK's Gonorrhea Vaccine Secures FDA Track
June 27, 2023
The FDA has granted Fast Track designation to GSK plc's (NYSE:
Via
Benzinga
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
June 26, 2023
As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other...
Via
Benzinga
Why Shares of CureVac Jumped This Week
June 23, 2023
The company, which focuses on mRNA therapies, began a phase 1 trial for its cancer vaccine candidate.
Via
The Motley Fool
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 23, 2023
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.
Via
Benzinga
GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms
June 23, 2023
GSK settled with James Goetz for an undisclosed amount of money. But thousands of cases remain.
Via
Investor's Business Daily
Crypto Analyst Says Bitcoin Can Break $32K Level, Nikola Moves Forward With Test Road Trips Despite Weak Demand & Internal Conflict, Retailers' Subscriptions Under FTC Scrutiny: Today's Top Stories
June 23, 2023
Benzinga
Via
Benzinga
GSK Confidentially Settles First Zantac-Associated Cancer Lawsuit Due For US Trial Next Month
June 23, 2023
GSK plc (NYSE: GSK) has reached a confidential settlement with James Goet
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.